Published in Cytokine on September 01, 1992
Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol (2002) 2.05
Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression. J Exp Med (1994) 1.66
Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin Exp Immunol (1995) 1.30
Genomic and proteomic biomarkers for cancer: a multitude of opportunities. Biochim Biophys Acta (2009) 1.03
Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas. Am J Pathol (1995) 1.00
IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer. Front Immunol (2011) 0.99
Interleukin-10 in the pathophysiology of inflammatory bowel disease: increased serum concentrations during the recovery phase. Mediators Inflamm (2006) 0.89
Loss of tissue expression of interleukin-10 promotes the disease progression of colorectal carcinoma. Surg Today (2009) 0.82
The clinical effects of dendritic cell vaccines combined with cytokine-induced killer cells intraperitoneal injected on patients with malignant ascites. Int J Clin Exp Med (2014) 0.79
Long-term interleukin-10 presence induces the development of a novel, monocyte-derived cell type. Clin Exp Immunol (2007) 0.77
Positive feedback regulation between IL10 and EGFR promotes lung cancer formation. Oncotarget (2016) 0.75
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity (2000) 16.03
Tuberculosis in Britain today. BMJ (1993) 6.17
Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science (1991) 6.12
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol (2000) 6.06
Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science (1992) 5.18
"Heartstart Scotland"--initial experience of a national scheme for out of hospital defibrillation. BMJ (1991) 4.56
RhoA is required for monocyte tail retraction during transendothelial migration. J Cell Biol (2001) 3.79
Retracted Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. J Immunol (1990) 3.76
Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol (1993) 3.51
Screening migrants at risk of tuberculosis. BMJ (1993) 3.34
Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol (2000) 3.30
Factors that determine false recall: a multiple regression analysis. Psychon Bull Rev (2001) 3.08
Socioeconomic deprivation and notification rates for tuberculosis in London during 1982-91. BMJ (1995) 3.06
Cytokine production at the site of disease in human tuberculosis. Infect Immun (1993) 3.04
Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol (1992) 3.03
Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax (2001) 3.01
Outbreak of isoniazid resistant tuberculosis in north London. Thorax (2004) 2.82
Evidence for genetic exchange and recombination of Rhizobium symbiotic plasmids in a soil population. Appl Environ Microbiol (1987) 2.76
DNA sequence of Rhizobium trifolii nodulation genes reveals a reiterated and potentially regulatory sequence preceding nodABC and nodFE. Nucleic Acids Res (1986) 2.68
IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol (1992) 2.67
T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57
The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors. Cell (1989) 2.52
The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol (1994) 2.50
Genetic and molecular characterization of the Pseudomonas plasmid pVS1. Plasmid (1984) 2.44
Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill (2011) 2.40
Chromosome mapping in Pseudomonas aeruginosa PAT. J Bacteriol (1978) 2.38
Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J Immunol (1989) 2.27
Heterogeneous case definitions used for the surveillance of influenza in Europe. Eur J Epidemiol (2003) 2.20
BCG immunisation in England and Wales: a survey of policy and practice in schoolchildren and neonates. BMJ (1992) 2.13
Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax (2002) 2.12
Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J Immunol (1987) 2.11
Malignant neoplasms arising in endometriosis. Obstet Gynecol (1990) 2.11
High-dose chemotherapy for breast cancer. Ann Intern Med (1996) 2.09
Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill (2006) 2.08
Distant metastases in epithelial ovarian carcinoma. Cancer (1987) 2.07
Active case finding for pulmonary tuberculosis using mobile digital chest radiography: an observational study. Int J Tuberc Lung Dis (2012) 2.00
Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest (1993) 2.00
Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol (1993) 2.00
Prevalence, morbidity and service need among South Asian and white adults with intellectual disability in Leicestershire, UK. J Intellect Disabil Res (2002) 1.98
Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science (1992) 1.98
Epidemiology and control of tuberculosis in Western European cities. Int J Tuberc Lung Dis (2003) 1.95
Tuberculosis among the homeless at a temporary shelter in London: report of a chest x ray screening programme. J Epidemiol Community Health (1995) 1.91
A G protein-coupled receptor for UDP-glucose. J Biol Chem (2000) 1.91
Monitoring tuberculosis treatment outcome: analysis of national surveillance data from a clinical perspective. Thorax (2007) 1.86
Suppressor mutations in Pseudomonas aeruginosa. J Bacteriol (1976) 1.81
Gamma delta T lymphocytes in human tuberculosis. J Infect Dis (1992) 1.78
Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med (1999) 1.77
Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med (1991) 1.77
The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06. N Engl J Med (1995) 1.74
Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect Immun (1993) 1.72
Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients. J Exp Med (1990) 1.71
Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies. Med Care (1992) 1.71
Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J Immunol (1995) 1.69
Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med (1996) 1.68
Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study) Gynecol Oncol (1993) 1.67
The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. Euro Surveill (2012) 1.67
Solvent encephalopathy. Br Med J (Clin Res Ed) (1981) 1.66
Mycobacterium bovis in England and Wales: past, present and future. Epidemiol Infect (1992) 1.64
Abuse of solvents "for kicks". A review of 50 cases. Lancet (1977) 1.62
Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill (2011) 1.61
Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis. Science (1986) 1.60
Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J Immunol Methods (1993) 1.60
Increasing incidence of right-sided lesions in colorectal cancer. Am J Surg (1979) 1.58
Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol (1994) 1.53
Notification of tuberculosis: an updated code of practice for England and Wales. J R Coll Physicians Lond (1997) 1.52
High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J Infect Dis (1996) 1.51
The impact of immigration on tuberculosis rates in the United Kingdom compared with other European countries. Int J Tuberc Lung Dis (2009) 1.50
Evaluating functional MRI procedures for assessing hemispheric language dominance in neurosurgical patients. Neuroradiology (2005) 1.49
Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol (1983) 1.49
A critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on Interferon gamma production. J Exp Med (2001) 1.48
Potential role for interleukin-10 in the immunosuppression associated with kala azar. J Clin Invest (1993) 1.47
A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposide. J Clin Oncol (1989) 1.46
Pathophysiology and management of endometrial hyperplasia and carcinoma. West J Med (1990) 1.44
Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol (1981) 1.44
Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii. Infect Immun (1993) 1.44
Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol (1991) 1.44
Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res (1990) 1.42
Characteristics of patients with small-volume residual ovarian cancer unresponsive to cisplatin-based ip chemotherapy: lessons learned from a Gynecologic Oncology Group phase II trial of ip cisplatin and recombinant alpha-interferon. Gynecol Oncol (1992) 1.42
Regulation of immunoglobulin (Ig)E synthesis in the hyper-IgE syndrome. J Clin Invest (1990) 1.42
Depressive illness in general practice: a pilot study. Health Bull (Edinb) (1981) 1.40
Human papillomavirus deoxyribonucleic acid in adenocarcinoma and adenosquamous carcinoma of the uterine cervix. Obstet Gynecol (1986) 1.40
IL-4- and IL-5-secreting lymphocyte populations are preferentially stimulated by parasite-derived antigens in human tissue invasive nematode infections. J Immunol (1993) 1.39
Reducing loss-to-follow-up among women with abnormal Pap smears. Results from a randomized trial testing an intensive follow-up protocol and economic incentives. Med Care (1998) 1.39
APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J Immunol (1999) 1.38
Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am J Obstet Gynecol (1991) 1.38
Influenza types and patient population. Lancet (1995) 1.37
Antibody-secreting cell precursor frequencies among the sheep-erythrocyte-binding cells after immunization. Scand J Immunol (1983) 1.37
Drug resistance in initial isolates of Mycobacterium tuberculosis in England and Wales, 1982-1991. Commun Dis Rep CDR Rev (1993) 1.36
Expression of murine and human granulocyte-macrophage colony-stimulating factors in S. cerevisiae: mutagenesis of the potential glycosylation sites. EMBO J (1986) 1.36
Functional heterogeneity among human inducer T cell clones. J Immunol (1988) 1.34
Construction of recombination-deficient strains of Pseudomonas aeruginosa. Mol Gen Genet (1983) 1.33
Genetic Diversity among Rhizobium leguminosarum bv. Trifolii Strains Revealed by Allozyme and Restriction Fragment Length Polymorphism Analyses. Appl Environ Microbiol (1991) 1.33
Parallel regulation of IL-4 and IL-5 in human helminth infections. J Immunol (1992) 1.33
Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill (2013) 1.32